Skip to content

Postoperative Radiotherapy for completely resected stage II/III thymoma

Postoperative Radiotherapy for completely resected stage II/III thymoma - Postoperative Radiotherapy for completely resected stage II/III thymoma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040729
Enrollment
Unknown
Registered
2020-06-12
Start date
2020-06-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymoma

Interventions

None listed

Sponsors

Yokohama city university graduate school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study selection, study design We will include an RCT and an observational study that compared surgery alone versus surgery plus postoperative radiation for stage II and III thymoma. A propensity score matched case-control study will be allowed. When an article evaluated stage I or IV patients along with stage II/III patient, the data for stage II/III subgroup should be extractable. An article will have to be written up as full articles, brief reports, or conference abstracts regardless of their primary end point. Non-English language reports will be excluded. Study selection, patient Patients with a pathologic or cytologic confirmed diagnosis of stage II and III thymoma will be included. Study selection, treatment The operation for stage II/III thymoma should be designed to completely resect the disease regardless of surgical procedure. Postoperative irradiation with any delivery method and radiation dosage will be allowed.

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
Hazard ratio of overall survival

Countries

Japan

Contacts

Public ContactNobuyuki Horita

Yokohama city university graduate school of medicine Department of pulmonology

horitano@yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026